Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a glossary display option; updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the previous QC term Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check54 days agoChange DetectedThe Study Record Dates section now displays a concrete 'Last Update Posted' timestamp, replacing the previous 'Last Update Posted (Estimated)' label. This clarifies the timing of the update without altering the underlying study data.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.